Public Event Detail
Eventide Asset Management LLC Has $26.01 Million Stock Holdings in Syndax Pharmaceuticals, Inc. $SNDX
Public historical observation from the Merrowstone archive. This page shows event-level context only. Accepted assertions, evidence lineage, and relationship intelligence remain part of the premium research layer.
Historical observations only. No forecasts, recommendations, buy/sell ratings, or portfolio advice.
2026-06-14JPMJPMorgan ChaseAlpha Vantage Newsearnings
Event summary
Eventide Asset Management LLC increased its stake in Syndax Pharmaceuticals (NASDAQ:SNDX) by 25.3% to include 1,238,196 shares valued at $26.01 million. Other institutional investors like Vanguard Group Inc., Bank of America Corp DE, and Qube Research & Technologies Ltd also significantly boosted their holdings. Despite recent insider share sales totalling over $1.3 million, analysts maintain a "Moderate Buy" rating for SNDX with an average price target of $42.55.
Attached public signals
Observed outcomes
7d returnPending
30d returnPending
90d returnPending
Relative 90d returnPending